Available at 5mg, is a synthetic research peptide commonly investigated in laboratory studies involving growth hormone-related signalling pathways, peptide stability models, and receptor interaction mechanisms.
Supplied as a high-purity lyophilised peptide powder, this compound is intended strictly for controlled in-vitro research applications alongside our broader range of research peptides UK laboratories rely on. Every batch supplied by Imperial Peptides UK undergoes independent third-party analytical testing, including HPLC purity verification, identity confirmation, heavy metal screening, and endotoxin analysis. Batch-specific Certificates of Analysis (CoAs) are provided to support analytical verification, laboratory traceability, and research documentation standards.
Specifications
SKU: CWD5
Form: Lyophilised peptide powder
Purity: ≥99%
Appearance: White lyophilised powder
Storage: Store at -20°C
After reconstitution: Store at 2–8°C
Chemical Information
Molecular Formula: C165H269N47O46
Molecular Weight: 3647.6 g/mol
CAS Number: Not assigned
→ Safety Data Sheet (SDS)
Research Applications
CJC-1295 (DAC) has been studied in a range of peptide research environments involving growth hormone signalling pathways, peptide half-life modelling, receptor-binding interactions, and long-acting peptide stability investigations. Researchers commonly utilise CJC-1295 (DAC) in broader in-vitro studies involving endocrine signalling and peptide interaction mechanisms.
→ View Research Reference Data (PubMed)
⚠︎ Safety & Legal Notice
This product is supplied strictly for in-vitro laboratory research use only. It is not intended for human or veterinary use, consumption, administration, or clinical application. The purchaser is responsible for ensuring compliance with all applicable laws and regulations relating to the handling and use of research materials.